NCT00364429View on ClinicalTrials.gov

SPECT Investigation Of The NMDA Receptor System In Healthy Volunteers And Patients With Schizophrenia

PHASE1TerminatedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions
Schizophrenia
Interventions
DRUG

[123]I-CNS 1261

Study Drug

DRUG

Lorazepam

Study Drug

DRUG

Risperidone

Study Drug

Trial Locations (1)

Unknown

GSK Investigational Site, Barcelona

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY